Attention deficit hyperactivity disorder in adults
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine available literature regarding attention deficit hyperactivity disorder (ADHD) in adults. METHODS: An electronic literature search of peer-reviewed English language articles using MEDLINE (without time limits) was undertaken. RESULTS: Symptoms of ADHD in adults exert a substantial negative impact on daily life, including work, social life and relationships. Co-morbidities are common, further impairing quality of life. Diagnosis of adult ADHD can be difficult, as current criteria require evidence of symptom onset before the age of 7 years and impact on activities typically undertaken by children. Drug therapy is the first-line treatment for adult ADHD, particularly stimulant medication. However, methylphenidate (MPH) immediate-release tablets require three or more times daily dosing, which can impact on compliance, while demonstrating a loss of symptomatic benefit later in the day. Extended-release preparations of MPH, mixed amphetamine salts and dexamphetamine can provide symptom control for 6-12 h and the non-stimulant atomoxetine has demonstrated benefit in reducing ADHD symptoms. These therapies are generally well tolerated, but may be associated with adverse effects on the cardiovascular system, which need to be further assessed in controlled clinical trials. Psychological therapy may be beneficial in adults who continue to experience clinically significant symptoms while receiving pharmacotherapy. CONCLUSION: Further research in all areas of adult ADHD is urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886 · cited 5×
“These surveys reported higher rates of ADHD in men than in women (Kessler et al. 2006; Fayyad et al. 2007a).”
InfluentialWillcutt, E. G., Doyle, A. E., Nigg, J. T., Faraone, S. V., & Pennington, B. F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.006 · Cited by 3,568
Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder
Fayyad, J., De Graaf, R., Kessler, R., Alonso, J., Angermeyer, M., Demyttenaere, K., De Girolamo, G., Haro, J. M., Karam, E. G., Lara, C., et al. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.034389 · Cited by 1,321 · cited 6×
“These surveys reported higher rates of ADHD in men than in women (Kessler et al. 2006; Fayyad et al. 2007a).”
InfluentialBush, G., Frazier, J. A., Rauch, S. L., Seidman, L. J., Whalen, P. J., Jenike, M. A., Rosen, B. R., & Biederman, J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00083-9 · Cited by 866
Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies
Michelson, D., Adler, L., Spencer, T., Reimherr, F. W., West, S. A., Allen, A. J., Kelsey, D., Wernicke, J., Dietrich, A., & Milton, D. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01671-2 · Cited by 790
Bush, G., Valera, E. M., & Seidman, L. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.034 · Cited by 714 · cited 1×
“Functional magnetic resonance imaging (MRI) studies using various types of inhibition tasks have consistently demonstrated reduced activation of the ventral prefrontal cortex and particularly the anterior cingulate cortex and the striatum in ADHD (Bush et al. 2005).”
Biederman, J., Faraone, S. V., Spencer, T. J., Mick, E., Monuteaux, M. C., & Aleardi, M. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0403 · Cited by 565
Executive functioning in adult ADHD: a meta-analytic review
MARIJE BOONSTRA, A., OOSTERLAAN, J., SERGEANT, J. A., & BUITELAAR, J. K. (2005) · Psychological Medicine · doi:10.1017/s003329170500499x · Cited by 560 · cited 1×
“Several cognitive functions, such as response and behavioural inhibition, attention, working memory and planning, are impaired in subjects with ADHD (Hervey et al. 2004; Boonstra et al. 2005; Willcutt et al. 2005).”
BackgroundSelf-citationCognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms
Safren, S. A., Otto, M. W., Sprich, S., Winett, C. L., Wilens, T. E., & Biederman, J. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.07.001 · Cited by 519 · cited 3×
“Whereas one study found the combination of ADHD drug treatment and CBT to be more effective than ADHD pharmacotherapy alone (Safren et al. 2005), a recent study did not find that ADHD medication significantly augmented the outcome of CBT therapy in adults with ADHD when compared to CBT and placebo (Weiss et al.”
BackgroundResultInfluentialMakris, N., Biederman, J., Valera, E. M., Bush, G., Kaiser, J., Kennedy, D. N., Caviness, V. S., Faraone, S. V., & Seidman, L. J. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhl047 · Cited by 450 · cited 1×
“Adults with ADHD also exhibit selective thinning of the cerebral cortex in the networks that mediate attention and executive functioning, especially in the right hemisphere involving the inferior parietal lobule, the dorsolateral prefrontal and the anterior cingulate cortices (Makris et al. 2007).”
Faraone, S. V., Spencer, T., Aleardi, M., Pagano, C., & Biederman, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000108984.11879.95 · Cited by 404
Diagnostic Controversies in Adult Attention Deficit Hyperactivity Disorder
McGough, J. J., & Barkley, R. A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1948 · Cited by 388
Sandra Kooij, J. J., Marije Boonstra, A., Swinkels, S. H. N., Bekker, E. M., de Noord, I., & Buitelaar, J. K. (2008) · Journal of Attention Disorders · doi:10.1177/1087054707299367 · Cited by 388
Self-citationSpencer, T., Biederman, J., Wilens, T., Doyle, R., Surman, C., Prince, J., Mick, E., Aleardi, M., Herzig, K., & Faraone, S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.043 · Cited by 385 · cited 3×
“…improved ” or “ very much improved ” (score of 2) on Clinical Global Impression – Improvement (CGI-I) plus 30% reduction in ADHD Investigator System Report Scale (AISRS) score from baseline was achieved by signifi cantly more patients receiving MPH-IR, compared with placebo (Spencer et al. 2005).”
Hesslinger, B., Tebartz van Elst, L., Nyberg, E., Dykierek, P., Richter, H., Berner, M., & Ebert, D. (2002) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-002-0379-0 · Cited by 366 · cited 1×
“DBT sessions were attended by the patients on a weekly basis, for a 3-month period (Hesslinger et al. 2002).”
de Graaf, R., Kessler, R. C., Fayyad, J., ten Have, M., Alonso, J., Angermeyer, M., Borges, G., Demyttenaere, K., Gasquet, I., de Girolamo, G., et al. (2008) · Occupational and Environmental Medicine · doi:10.1136/oem.2007.038448 · Cited by 355 · cited 1×
“The work productivity of adults with ADHD is also lower than that of other adults, due to concentration diffi culties, disorganization, and a reduced ability to cope with a large workload (Biederman et al. 2006a; de Graaf et al. 2008).”
ADHD Drugs and Cardiovascular Risk
Nissen, S. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068049 · Cited by 331
Volkow, N. D., Wang, G.-J., Newcorn, J., Telang, F., Solanto, M. V., Fowler, J. S., Logan, J., Ma, Y., Schulz, K., Pradhan, K., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.8.932 · Cited by 331
Faraone, S. V., Biederman, J., Spencer, T., Mick, E., Murray, K., Petty, C., Adamson, J. J., & Monuteaux, M. C. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.10.1720 · Cited by 329 · cited 3×
“In addition, patterns of co-morbidity, familial loading for ADHD and neuropsychological defi cits are very similar for so-called late-onset ADHD and ADHD meeting the full DSM-IV-TR criteria (Faraone et al. 2006a,b).”
The marital and family functioning of adults with ADHD and their spouses
Eakin, L., Minde, K., Hechtman, L., Ochs, E., Krane, E., Bouffard, R., Greenfield, B., & Looper, K. (2004) · Journal of Attention Disorders · doi:10.1177/108705470400800101 · Cited by 318 · cited 1×
“In a 6-week study, MPH-IR 1.0 – 1.3 mg/kg per day signifi cantly improved ADHD-RS total score versus for their partner ’ s diffi culties, which may place considerable strain on the relationship (Eakin et al. 2004).”
InfluentialStructural brain change in Attention Deficit Hyperactivity Disorder identified by meta-analysis
Ellison-Wright, I., Ellison-Wright, Z., & Bullmore, E. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-51 · Cited by 269
Biederman, J., Mick, E., Surman, C., Doyle, R., Hammerness, P., Harpold, T., Dunkel, S., Dougherty, M., Aleardi, M., & Spencer, T. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.011 · Cited by 267
A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder
Stevenson, C. S., Whitmont, S., Bornholt, L., Livesey, D., & Stevenson, R. J. (2002) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2002.01052.x · Cited by 261 · cited 1×
“Notably, the improvements in symptoms and organizational skills were maintained at 1 year following the intervention (Stevenson et al. 2002).”
Nutt, D. J., Fone, K., Asherson, P., Bramble, D., Hill, P., Matthews, K., Morris, K. A., Santosh, P., Sonuga-Barke, E., Taylor, E., et al. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106073219 · Cited by 259 · cited 1×
“…organizations, including the National Institute of Mental Health, the American Academy of Child and Adolescent Psychiatry (AACAP), the Canadian ADHD Resource Alliance (CADDRA) and the British Association for Psychopharmacology (BAP) (Dulcan 1997; Jain et al. 2006; Nutt et al. 2007; NIMH 2009).”
Emotional Dysregulation in Adult ADHD and Response to Atomoxetine
Reimherr, F. W., Marchant, B. K., Strong, R. E., Hedges, D. W., Adler, L., Spencer, T. J., West, S. A., & Soni, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.040 · Cited by 258 · cited 1×
“This was a greater reduction than that reported for patients without ED (Reimherr et al. 2005).”
Swanson, J., Gupta, S., Lam, A., Shoulson, I., Lerner, M., Modi, N., Lindemulder, E., & Wigal, S. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.2.204 · Cited by 248
Adler, L. A., Goodman, D. W., Kollins, S. H., Weisler, R. H., Krishnan, S., Zhang, Y., & Biederman, J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0903 · Cited by 218
Ehlis, A.-C., Bähne, C. G., Jacob, C. P., Herrmann, M. J., & Fallgatter, A. J. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.11.011 · Cited by 209 · cited 1×
“This was particularly marked for the task involving working memory (Ehlis et al. 2008).”
Fischer, M., Barkley, R. A., Smallish, L., & Fletcher, K. (2007) · Accident Analysis & Prevention · doi:10.1016/j.aap.2006.06.008 · Cited by 200 · cited 1×
“…to the impulsivity, inattention, loss of concentration and fatigue associated with the condition, resulting in overall poor driving performance and specifi c problems such as variable reaction times and risk taking (Fried et al. 2006; Richards et al. 2006; Fischer et al. 2007; Reimer et al. 2007).”
Cardiovascular Effects of Atomoxetine in Children, Adolescents, and Adults
Wernicke, J. F., Faries, D., Girod, D., Brown, J. W., Gao, H., Kelsey, D., Quintana, H., Lipetz, R., Michelson, D., & Heiligenstein, J. (2003) · Drug Safety · doi:10.2165/00002018-200326100-00006 · Cited by 191
Medori, R., Ramos-Quiroga, J. A., Casas, M., Kooij, J. J. S., Niemelä, A., Trott, G.-E., Lee, E., & Buitelaar, J. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.11.008 · Cited by 186 · cited 6×
“In addition, severity of illness, as measured by CGI-S, was signifi cantly reduced from baseline with all doses of OROS MPH versus placebo ( P 0.05 for all comparisons) (Medori et al. 2008).”
InfluentialSelf-citationReimherr, F. W., Williams, E. D., Strong, R. E., Mestas, R., Soni, P., & Marchant, B. K. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0113 · Cited by 180
KOOIJ, J. J. S., BURGER, H., BOONSTRA, A. M., VAN DER LINDEN, P. D., KALMA, L. E., & BUITELAAR, J. K. (2004) · Psychological Medicine · doi:10.1017/s0033291703001776 · Cited by 163 · cited 2×
“…the short-term, with the most commonly reported adverse events being tremor, anxiety, restlessness, diarrhoea or constipation, headache, dryness of mouth, dizziness, insomnia, loss of appetite (Faraone et al. 2004; Kooij et al. 2004; Spencer et al. 2005; Biederman et al. 2006b; Medori et al. 2008).”
Self-citationWeisler, R. H., Biederman, J., Spencer, T. J., Wilens, T. E., Faraone, S. V., Chrisman, A. K., Read, S. C., & Tulloch, S. J. (2006) · CNS Spectrums · doi:10.1017/s1092852900013687 · Cited by 158 · cited 3×
“The effects of MAS extended release (MAS-ER) 20, 40 or 60 mg/day in adults with ADHD was compared with placebo over a 4-week study period (Weisler et al. 2006).”
Influentialon behalf of the study group, Rösler, M., Fischer, R., Ammer, R., Ose, C., & Retz, W. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-008-0845-4 · Cited by 155
Self-citationSobanski, E., Schredl, M., Kettler, N., & Alm, B. (2008) · Sleep · doi:10.1093/sleep/31.3.375 · Cited by 153 · cited 1×
“…with later sleep onset, and reduced sleep duration, the number and total duration of nocturnal awakenings is reduced, with a corresponding increase in the mean duration of within-night periods of uninterrupted sleep; i.e. improved sleep quality (Boonstra et al. 2007; Sobanski et al. 2008).”
Spencer, T. J., Biederman, J., Madras, B. K., Dougherty, D. D., Bonab, A. A., Livni, E., Meltzer, P. C., Martin, J., Rauch, S., & Fischman, A. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.008 · Cited by 150 · cited 2×
“The involvement of the dopamine transporter in ADHD has been supported by the results of a positron emission tomography (PET) study, which demonstrated its increased availability in adult ADHD patients versus matched controls (Spencer et al. 2007a).”
Faraone, S. V., Biederman, J., Doyle, A., Murray, K., Petty, C., Adamson, J. J., & Seidman, L. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.060 · Cited by 138 · cited 3×
“In addition, patterns of co-morbidity, familial loading for ADHD and neuropsychological defi cits are very similar for so-called late-onset ADHD and ADHD meeting the full DSM-IV-TR criteria (Faraone et al. 2006a,b).”
Cox, D. J., Merkel, R. L., Penberthy, J. K., Kovatchev, B., & Hankin, C. S. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200403000-00007 · Cited by 120
Bupropion SR vs. Methylphenidate vs. Placebo for Attention Deficit Hyperactivity Disorder in Adults
Kuperman, S., Perry, P., Gaffney, G., Lund, B., Bever-Stille, K., Arndt, S., Holman, T., Moser, D., & Paulsen, J. (2001) · Annals of Clinical Psychiatry · doi:10.3109/10401230109148958 · Cited by 113
Asherson, P., Chen, W., Craddock, B., & Taylor, E. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.026484 · Cited by 105
Adler, L. A., Sutton, V. K., Moore, R. J., Dietrich, A. P., Reimherr, F. W., Sangal, R. B., Saylor, K. E., Secnik, K., Kelsey, D. K., & Allen, A. J. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000239797.21826.70 · Cited by 79 · cited 2×
“Mean reductions from baseline in CAARS:O-S total score, and the inattentive and hyperactive/impulsive scores were signifi cantly greater for atomoxetine 40 mg bd versus 80 mg qd (all P 0.001) (Adler et al. 2006a).”
InfluentialHepatic Events Associated with Atomoxetine Treatment for??Attention-Deficit??Hyperactivity Disorder
Bangs, M. E., Jin, L., Zhang, S., Desaiah, D., Allen, A. J., Read, H. A., Regev, A., & Wernicke, J. F. (2008) · Drug Safety · doi:10.2165/00002018-200831040-00008 · Cited by 68
Ramos-Quiroga, J. A., Bosch, R., Castells, X., Valero, S., Nogueira, M., Gómez, N., Yelmo, S., Ferrer, M., Martínez, Y., & Casas, M. (2008) · CNS Drugs · doi:10.2165/00023210-200822070-00005 · Cited by 54 · cited 1×
“Similarly, results from a chart review of Spanish adults with ADHD reported that switching from MPH-IR to OROS MPH was associated with an improvement in compliance, as rated by the Simplifi ed Medication Adherence Questionnaire (Ramos-Quiroga et al. 2008).”
Self-citationLong-Term Effectiveness and Safety of Dexmethylphenidate Extended-Release Capsules in Adult ADHD
Adler, L. A., Spencer, T., McGough, J. J., Jiang, H., & Muniz, R. (2009) · Journal of Attention Disorders · doi:10.1177/1087054708320397 · Cited by 53 · cited 3×
“Improvement in both measures was evident from Week 1 onwards (Adler et al. 2008).”
InfluentialFaraone, S. V. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.9.1565 · Cited by 33
Cited by
Matheson, L., Asherson, P., Wong, I. C. K., Hodgkins, P., Setyawan, J., Sasane, R., & Clifford, S. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-184 · Cited by 126
“This can result in significant impairments across multiple domains of adult life, affecting interpersonal relationships, family dynamics, education, occupation and overall health-related quality of life [1,10,11].”
BackgroundResultInfluentialGiacobini, M., Medin, E., Ahnemark, E., Russo, L. J., & Carlqvist, P. (2018) · Journal of Attention Disorders · doi:10.1177/1087054714554617 · Cited by 94
Retz, W., Rösler, M., Ose, C., Scherag, A., Alm, B., Philipsen, A., Fischer, R., Ammer, R., & The Study Group (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.540257 · Cited by 79
Self-citationCunill, R., Castells, X., Tobias, A., & Capellà, D. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3473 · Cited by 70
Wu, E. Q., Hodgkins, P., Ben-Hamadi, R., Setyawan, J., Xie, J., Sikirica, V., Du, E. X., Yan, S. Y., & Erder, M. H. (2012) · CNS Drugs · doi:10.2165/11633900-000000000-00000 · Cited by 58
Metadata
- Authors
- Rösler, M., Casas, M., Konofal, E., & Buitelaar, J.
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2010-06-03
- Volume
- 11
- Issue
- 5
- Pages
- 684-698
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2151431105
- Cited by
- 143
- References
- 46
- FWCI
- 8.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.